THREE EX-BARCLAYS BANKERS CONVICTED OVER LIBOR SCANDAL
cityam-2016-07-05-577af9476f73f
cityam-2016-07-05-577af9476f73f
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CITYAM.COM<br />
TUESDAY 5 JULY 2016<br />
NEWS<br />
11<br />
Pharma industry<br />
in UK could gain<br />
from Brexit vote<br />
BILLY BAMBROUGH<br />
@BillyBambrough<br />
THE UK pharmaceuticals sector could<br />
benefit from the country’s vote to quit<br />
the European Union, according to new<br />
research.<br />
A loss of some funding and a socalled<br />
brain drain as employees relocate<br />
abroad in the short term is not<br />
expected to have a significant impact<br />
on long term growth, business intelligence<br />
firm BMI Research found.<br />
“While the bearish case for the UK’s<br />
pharmaceutical research and development<br />
(R&D) sector as a result of Brexit<br />
has been widely articulated, the<br />
upside risks are underappreciated,”<br />
the report authors wrote.<br />
BMI found the UK’s strong scientific<br />
base and existing R&D partnerships<br />
with companies and organisations<br />
across the EU will allow it to enter<br />
negotiations for the continued access<br />
to EU R&D funds. The report did warn<br />
over the risks associated with renegotiation<br />
of the UK’s trade deals.<br />
“Hammering out deals with the EU<br />
over the coming years will entail a<br />
great deal of time and uncertainty,<br />
and there is a risk that the UK will<br />
receive a punitive deal as it will be<br />
negotiating from a perceived position<br />
of weakness,” BMI analysts wrote.<br />
“However, amid the negative sentiment<br />
surrounding the UK’s prospects<br />
of going it alone, we highlight that the<br />
UK’s world class science base, its<br />
strong position within the global R&D<br />
arena and the country’s international<br />
research collaborations will work<br />
towards keeping British science at the<br />
forefront of research.”<br />
Pharma accounted for the highest<br />
level of business R&D expenditure for<br />
a product group in 2014, according to<br />
the Office for National Statistics. It<br />
represented 20 per cent of total expenditure<br />
and clocked up almost £4bn of<br />
spending. It was followed by<br />
computer programming and information<br />
services activities at £2.35bn.<br />
SUPER RESULTS High street chemist<br />
Superdrug sees profits rise 62 per cent<br />
SUPERDRUG is set to file accounts at companies house showing operating profit of<br />
£62.2m in 2015, up from £38.2m the year before. Sales from like-for-like stores<br />
increased by 6.6 per cent, with make-up and beauty growing 11 per cent.<br />
Small business<br />
confidence fell<br />
before Brexit<br />
HELEN CAHILL<br />
@HelCahill<br />
SMALL business confidence was at<br />
a four-year low before the EU<br />
referendum, according to data<br />
from the Federation of Small<br />
Businesses (FSB).<br />
A survey from the FSB,<br />
conducted before the Brexit vote,<br />
also found smaller companies are<br />
planning to cut jobs for a second<br />
quarter in a row. Members said<br />
their profits are falling due to the<br />
increased cost of labour and tax<br />
burdens.<br />
Only 12.2 per cent of businesses<br />
surveyed said they planned new<br />
capital investment over the next<br />
year - down from 31.9 per cent a<br />
year ago.<br />
Mike Cherry, FSB chairman, said<br />
the government should push<br />
forward on expanding small<br />
business rate relief and that the<br />
Low Pay Commission should be<br />
“especially vigilant” when making<br />
recommendations on minimum<br />
wage rates next year.<br />
“We need to do everything we<br />
can to support small firms to grow,<br />
create jobs, and weather the harsh<br />
economic headwinds,” he added.<br />
Clarkson’s share price sinks after it<br />
warns profits will be lower this year<br />
HELEN CAHILL<br />
@HelCahill<br />
SHIPBROKER Clarkson’s share price<br />
tanked 16.1 per cent to 1,850p<br />
yesterday after the group said its<br />
profits will be “materially lower” this<br />
year.<br />
The group said global economic<br />
uncertainty and an imbalance<br />
between supply and demand in<br />
shipping and offshore meant the<br />
industry “remains depressed”,<br />
despite the recovery of oil prices.<br />
The FTSE 250 group said: “While<br />
recent strengthening of the US<br />
dollar against sterling, if sustained,<br />
will offer some limited enhancement<br />
to reported profits, the board<br />
anticipates that as a consequence of<br />
the challenges... profits for 2016 will<br />
be materially lower.”<br />
CLARKSON<br />
2,300 P<br />
2,200<br />
2,100<br />
2,000<br />
1,900<br />
1,800<br />
1,700<br />
4 July<br />
1,850.00<br />
28 June 29 June 30 June 1 July<br />
4 July<br />
Fund manager to keep London<br />
as European base after Brexit<br />
WILLIAM TURVILL<br />
@wturvill<br />
COLUMBIA Threadneedle has committed<br />
to keeping its European headquarters<br />
in London after Brexit.<br />
The fund manager confirmed it has<br />
“begun the process of applying to<br />
expand the scope of our Luxembourgbased<br />
management company to<br />
enable us to establish an asset management<br />
presence in the EU”.<br />
But a spokesperson added: “We will<br />
not be moving our EMEA<br />
headquarters from London and the<br />
vast majority of our employees can<br />
expect to remain where they are currently<br />
located.”<br />
The commitment to London comes<br />
at a time when several asset managers<br />
are being linked with staff and fund<br />
movements away from the UK.<br />
The Investment Association is holding<br />
a meeting today to discuss the<br />
impact of Brexit with its asset<br />
manager members.